Home » Comparison Articles

Image for Head to Head Comparison: Yubo International Biotech (YBGJ) vs. Its Competitors

Head to Head Comparison: Yubo International Biotech (YBGJ) vs. Its Competitors

Risk and Volatility Yubo International Biotech has a beta of 2.99, meaning that its stock price is 199% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s peers have a beta of 16.24, meaning that... More of this article »
Image for TruGolf (TRUG) versus Its Competitors Head to Head Contrast

TruGolf (TRUG) versus Its Competitors Head to Head Contrast

Insider & Institutional Ownership 3.2% of TruGolf shares are owned by institutional investors. Comparatively, 49.9% of shares of all “Sporting & athletic goods, not elsewhere classified” companies are owned by... More of this article »
Image for Evertz Technologies (OTCMKTS:EVTZF) vs. u-blox (OTCMKTS:UBLXF) Head-To-Head Analysis

Evertz Technologies (OTCMKTS:EVTZF) vs. u-blox (OTCMKTS:UBLXF) Head-To-Head Analysis

Evertz Technologies (OTCMKTS:EVTZF – Get Free Report) and u-blox (OTCMKTS:UBLXF – Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based... More of this article »
Image for Comparing Stagecoach Group (OTCMKTS:SAGKF) & Lotus Technology (NASDAQ:LOT)

Comparing Stagecoach Group (OTCMKTS:SAGKF) & Lotus Technology (NASDAQ:LOT)

Lotus Technology (NASDAQ:LOT – Get Free Report) and Stagecoach Group (OTCMKTS:SAGKF – Get Free Report) are both auto/tires/trucks companies, but which is the superior investment? We will compare the two companies based... More of this article »
Image for Head to Head Survey: Adverum Biotechnologies (NASDAQ:ADVM) and Scinai Immunotherapeutics (NASDAQ:SCNI)

Head to Head Survey: Adverum Biotechnologies (NASDAQ:ADVM) and Scinai Immunotherapeutics (NASDAQ:SCNI)

Scinai Immunotherapeutics (NASDAQ:SCNI – Get Free Report) and Adverum Biotechnologies (NASDAQ:ADVM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two... More of this article »